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High fiber rye foods decrease body weight and body fat 
and affect metabolic risk markers 
KIA NØHR IVERSEN 
Department of Biology and Biological Engineering 
Chalmers University of Technology, Gothenburg, Sweden 
Abstract 
Overweight and obesity are major risk factors for development of non-communicable 
diseases, such as type-2 diabetes and cardiovascular disease, and increase the risk of early 
mortality. Diet and food consumption are among the most important factors in preventing 
and reversing overweight, obesity and their comorbidities. Whole grain has been associated 
with decreased risk of overweight and obesity in observational studies, but the results from 
interventions are inconsistent. This may be because very few interventions have been 
adequately designed for evaluation of the effects of whole grain on body weight management 
and these effects may differ between different whole grain sources. Rye is the cereal with the 
highest fiber content and has been suggested to be superior to wheat in inducing beneficial 
physiological effects with health implications, but large randomized controlled trials with 
well-characterized intervention foods are lacking. This thesis aimed to investigate the effects 
of rye-based cereals, compared with refined wheat-based cereals, on body weight loss and 
metabolic risk factors. Furthermore, the potential influence of subjective appetite and gut 
microbiota were investigated. High fiber rye-based cereal products were shown to induce 
greater reduction in body weight and body fat than corresponding refined wheat products 
after 6 and 12 weeks of intervention among overweight and obese men and women. No 
consistent effect of rye products on appetite response was found and the changes in body 
weight and body fat could not be linked to differences in subjective appetite or food intake. 
However, this may be due to methodological issues and warrants further research. Compared 
with refined wheat products, high fiber rye-based cereal products were shown to lower C-
reactive protein, a marker of inflammation and a risk factor for cardiovascular disease, in two 
different populations. This effect was associated with reduction in abundance of certain 
bacteria in the gut that have previously been associated with decreased gut barrier integrity, 
suggesting that the effect of rye consumption on inflammation may, at least partly, be 
mediated through changes in gut microbiota composition and decreased gut permeability. In 
conclusion, the work included in this thesis suggests that replacing wheat-based cereals with 
high fiber rye-based cereals can aid the reduction of body weight and body fat, and reduce 
low-grade inflammation. These results can support the development of dietary guidelines and 
promote the development of healthier food products. 
Keywords: rye, wheat, whole grain, cereals, dietary fiber, weight loss, appetite, gut 
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Overweight and obesity are major risk factors for development of non-communicable 
diseases (NCDs), such as type-2 diabetes, cardiovascular diseases and certain cancers, and it 
has been estimated that overweight and obesity may account for as many as 4 million deaths 
annually [1, 2]. Overweight and obesity can have negative effects on quality of life, as both 
conditions increase the risk of living with disease and disability [1], in addition to having huge 
costs for society [3]. It is estimated that 2 billion people are overweight worldwide, of whom 
more than 600 million are obese [2, 4]. In Sweden, over 50% of the adult population aged 16–
84 years is overweight or obese and the numbers have been increasing over the past decade 
[5].  
Overweight is defined as body mass index (BMI) ≥ 25 kg/m2 and obesity as BMI ≥ 30 kg/m2, 
though it has been suggested that the cut-offs in certain Asian-Pacific populations should be 
1–2 kg/m2 lower [6, 7]. Fundamentally, overweight and obesity are caused by an imbalance 
between energy intake and energy expenditure leading to accumulation of energy in the form 
of excess body fat [8]. However, the underlying causes of this imbalance are more complex 
and influenced by many factors, such as environment, genetics and medical conditions. 
Recently, other factors such as gut microbiota have also been suggested to be of importance 
[9]. However, diet and food consumption remain among the most important aspects for 
preventing and reversing overweight and obesity and their comorbidities [10, 11]. 
Carbohydrate-rich foods, including cereals, fruits, legumes and starchy vegetables, constitute 
the main energy source for the vast majority of populations worldwide and most dietary 
guidelines promote consumption of such foods [12, 13]. However, over the past decades, a 
decrease in carbohydrate intake has been seen, which may in part be a result of a rise in fad 
diets focusing on reducing carbohydrate intake and in some cases giving carbohydrates a bad 
reputation [14–16]. Carbohydrates include a wide range of molecules, from easily absorbed 
simple sugars to complex fibers resistant to enzymatic digestion and absorption, which have 
very different physiological effects and health implications. In line with this, recent research 
has shown that carbohydrate quality may be more important than carbohydrate quantity in 
determining the effects of carbohydrate consumption on human health [17]. Furthermore, 
carbohydrate-rich foods, such as cereals and legumes, have a much lower environmental 
impact than animal-based products, which can be considered a reason to encourage 
continued and even increased consumption of such foods [18].  
Whole grain cereals are rich in dietary fiber and a range of bioactive components, and have 
consistently been associated with decreased risk of overweight, obesity and NCDs, making 
whole grain cereals a good source of high-quality carbohydrates [19, 20].  
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While whole grain consumption has consistently been associated with reduced risk of 
overweight and obesity in observational studies, there is a lack of data from appropriately 
designed intervention studies. Such studies are needed to establish a causal link between 
whole grain consumption and body weight management and to increase the understanding 
of the underlying mechanisms. Furthermore, causality must be established before specific 
health effects of whole grains can be communicated to consumers, for instance through so-
called health claims authorized by the European Commission [21].  
Among cereals, rye has the highest content of dietary fiber and has been suggested to induce 
beneficial physiological effects with implications for human health, such as enhanced satiety, 
decreased insulin response and reductions in blood lipids [22]. Enhanced satiety could in 
theory lead to reduced body weight, and satiety-enhancing foods could be a valuable tool in 
preventing and reversing overweight and obesity [23]. However, there is a need for studies 
testing the causal link between consumption of satiety-enhancing foods and long-term weight 
management, to understand how satiety-enhancing products may be used to prevent and 
reverse overweight and obesity. Recently, gut microbiota has emerged as a potential 
mediator of the health effects proposed to be induced by whole grain, and gut microbiota 
composition has in some cases been shown to determine the magnitude of weight loss 
induced by cereal fiber consumption [24, 25]. 
In summary, there is a need for well-designed interventions that can provide causal evidence 
for the effect of whole grain on body weight regulation, and prove a link between 
consumption of satiety-enhancing foods and body weight loss. Closing these gaps is important 
for the development of more effective dietary guidelines and for development and marketing 






The overall aim of the thesis was to evaluate the effects of high fiber rye-based foods 
compared with commonly consumed refined wheat-based foods on weight loss and 
metabolic risk factors, to aid reduction of the prevalence of overweight and obesity and their 
comorbidities. 
The specific objectives were: 
A. To investigate the effects of a high fiber whole grain rye-based diet, compared with a 
refined wheat diet, on weight loss (Paper I). 
B. To explore the potential mechanistic effect of appetite on weight loss and investigate 
factors that may influence appetite response to typical rye-based cereal products 
(Papers I and IV). 
C. To explore the potential influence of gut microbiota on weight loss in response to a 
whole grain rye-based diet (Paper II). 
D. To investigate the effects on metabolic risk markers of a diet rich in high fiber rye-






3.1 Cereals and human health 
Cereals are major part of the diet in many areas of the world, but the consumption of cereals 
varies between different countries as regards both grain species and amounts [26]. Many 
countries in northern Europe, especially in Scandinavia, have a relatively high intake of rye-
based cereal products [27, 28], whereas the cereal intake in southern Europe is dominated by 
wheat [29]. Oats and barley are consumed in several European countries, but to a lesser 
extent than wheat and rye. A large proportion of the rye consumed in northern Europe is in 
the form of whole grain, while many wheat products are typically based on refined wheat. 
Whole grain food intake is recommended by governmental authorities as part of the official 
dietary guidelines in many countries, but the exact recommendations differ somewhat 
between countries, ranging from encouragement to “choose whole grains whenever 
consuming cereals” to listing specific amounts of whole grain to be consumed on a daily basis 
[30].  
There is currently no globally accepted definition of whole grains or whole grain products [31]. 
Attempts have been made to unify the definitions, and the Health Grain Forum, which is a 
European association of academic and industrial parties with an interest in cereals, proposed 
the following definition of whole grains: “Whole grains shall consist of the intact, ground, 
cracked or flaked kernel after the removal of inedible parts such as the hull and husk. The 
principal anatomical components – the starchy endosperm, germ and bran – are present in 
the same relative proportions as they exist in the intact kernel” [32]. Similar definitions have 
been adopted by other major regulatory bodies within the food sector [33, 34]. Though an 
official global definition regarding whole grain is lacking, there is a relatively strong consensus 
on what constitutes whole grain; the definition of a whole grain product varies more, though 
some suggestions for guidelines has been made [35]. Many products consist of a mixture of 
whole grain and refined grain and the actual whole grain content in products marked whole 
grain may vary substantially [35]. In some countries, attempts have been made to standardize 
the definition of a whole grain product, for instance through the use of a whole grain logotype 
by a public-private partnership in Denmark [36] and the Nordic “keyhole,” which was 
originally developed by the Swedish National Food Agency in the 1980s and later adapted by 
the Nordic Council and used in several Nordic countries [37, 38]. 
Consumption of whole grains has consistently been associated with better health status in 
observational studies, whereas refined grains have in some studies been associated with 
increased disease risk and have in other studies not been associated with either increased or 
decreased risk of disease [39–41]. Whole grain consumption has for example been associated 
with decreased risk of developing type-2 diabetes, cardiovascular disease and certain cancers 
[39, 42–45]. Furthermore, whole grain consumption has been inversely associated with BMI 
and body weight, and seems to decrease the risk of overweight and obesity [46–49]. These 
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potential health effects have been attributed to many different components of whole grain 
cereals, but cereal fiber has been suggested to be one of the main contributors, although it 
has been shown to be difficult to separate the independent effects of bioactive compounds 
and those of dietary fiber per se [19, 50]. Dietary fiber refers to carbohydrate polymers from 
plants which are resistant to enzymatic digestion and absorption in the upper gastrointestinal 
(GI) tract and therefore pass undigested into the colon, where they to varying degree undergo 
digestion by the gut microbiota [51]. Dietary fiber is well established as an important part of 
a healthy diet, but the term covers a wide range of different fiber components from different 
sources. Their functionalities vary and thus it is likely that the specific health effects vary 
depending on the type and source of fiber [52–54]. The physiological effects of dietary fiber 
also range widely, from slowed gastric emptying and digestion of the food matrix in the upper 
GI tract and binding of various components hindering absorption, to acting as a substrate for 
the gut microbiota in the colon [52–55]. The gut microbiota has been suggested to be involved 
in the potential health effects of whole grain consumption [56]. However, whole grain-based 
interventions have shown a limited ability to alter the gut microbiota composition. This may 
be due to the fact that many studies have relatively low power and that changing only part of 
the diet (e.g., replacing habitual cereals with intervention cereals) may not be sufficient to 
induce major changes in the gut microbiota composition, especially in populations with high 
habitual intake of fiber-rich cereals [57–59].  
Whole grains have a higher content of micronutrients and bioactive components than their 
refined counterparts. This is due to the fact that many such components in cereals are located 
in the outer bran and germ layers, which are often removed when grain is processed into 
refined cereal products [50]. There are also differences between different cereal sources; for 
instance, rye has an especially high content of lignans and benzoxazinoids and wheat has a 
high content of selenium [55, 60, 61].  
 
3.2 Cereals and body weight management 
Body weight management refers to interventions and strategies aiming at reaching and 
maintaining optimal body weight. The term optimal body weight often refers to the body 
weight and body composition that is optimal for promotion of health and prevention of 
disease and disability [62]. Body weight management can involve both weight gain and weight 
loss, as well as maintenance of a stable body weight [63], but in this thesis the main focus is 
on aspects related to weight loss.  
A high intake of whole grain or cereal fiber has consistently been shown to be associated with 
lower BMI and lower risk of developing overweight and obesity in observational studies. A 
recent meta-analysis of cross-sectional cohort studies found an inverse association between 
whole grain consumption and BMI, i.e., study participants who reported a higher intake of 
whole grains had a lower BMI [64]. The same meta-analysis found an overall inverse 
association between whole grain intake and weight gain in prospective cohorts with a follow-
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up time of 5–20 years [64]. Other meta-analyses have confirmed the inverse association 
between whole grain or cereal fiber consumption and obesity measures in prospective 
cohorts [65]. While observational studies enable studies of dietary patterns and their 
associations with health outcomes in large populations over long periods of time, they also 
suffer from measurement errors and potential confounding. Consumption of healthy foods, 
such as whole grains and cereal fiber, is often associated with a generally healthy diet and 
other healthy lifestyle patterns such as increased physical activity [28, 66, 67]. This means 
that it may be difficult to completely disentangle the potential health effects of each 
individual component of the lifestyle. A way to overcome this challenge and reduce the risk 
of confounding is to use randomized controlled intervention studies where participants are 
randomly assigned to specific treatment groups, such as one group eating whole grain 
products and another eating refined grain products [68].  
 
3.2.1 Evidence from randomized intervention studies 
While the results from observational studies show a clear link between whole grain intake or 
high cereal fiber intake and lower risk of overweight and obesity, the results from 
interventions are inconsistent [69, 70]. A meta-analysis from 2013 concluded that there was 
no beneficial effect on body weight on whole grain consumption, but indications of a small 
effect on body fat, and an updated meta-analysis from 2020 confirmed the finding of no effect 
of whole grains on obesity measures [69, 70]. The reason for the differential results when 
comparing observational studies and intervention studies may be related to the fact that very 
few of the interventions included in the meta-analyses were designed to investigate the 
effects of cereals on body weight. In fact, many were designed for investigation of outcomes 
sensitive to changes in weight and measures to prevent weight change were implemented in 
some studies. Table 3.1 summarizes randomized controlled cereal interventions, the majority 
of which were included in the aforementioned meta-analyses [69, 70]. Out of the 38 studies 
included in the table, only five were designed to investigate effects on obesity measures (body 
weight, body composition and abdominal fat mass) [71–75]. All the other studies were 
designed for other purposes and some even implemented measures to maintain stable 
weight throughout, ranging from simply instructing participants to maintain a stable weight 
[76–78] to regularly checking participants’ weight and intervening if it changed [79, 80]. These 
are not optimal conditions for investigating the effects on body weight and might explain why 
most of the studies showed no effect of the intervention on body weight. Some studies that 
were not designed to investigate body weight did ask participants to replace their habitual 
cereals with intervention products on an ad libitum basis without further dietary restriction. 
These studies might add to the understanding of the effect of cereals on body weight 
regulation, which could be mediated through increased satiation or satiety and lower food 
intake following consumption of certain cereals. Nonetheless, it is still questionable to what 
extent most of the studies can be used to accurately address the question of cereal 
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consumption and weight management. It is unfortunate that this has not been highlighted to 
a greater extent in scientific reviews and meta-analyses. 
Table 3.1 reveals a strikingly large variation in types and amounts of intervention foods used 
across studies. Many studies investigated mixtures of multiple cereal sources, but there were 
also many specifically focusing on wheat or oats. Different cereals vary greatly in nutritional 
composition. For instance, the fiber content varies from 6% in whole grain rice up to 20% in 
whole grain rye [22]. Furthermore, the fiber composition also varies greatly, with oats and 
barley having a high amount of soluble, viscous beta-glucans, whereas rye and wheat are 
dominated by a mixture of soluble fiber and primarily insoluble arabinoxylans [81]. These 
differences in composition could likely influence the physiological effects in the human body 
after consumption and there may be a need for greater distinction between different cereals 
to get a better understanding of the health effects of cereals. Moreover, processing affects 
the physiochemical properties of dietary fiber, which could also influence the physiological 
effects [82–84]. 
Rye has the highest fiber content of all cereals and has been suggested to be superior to other 
cereal types as regards health effects [22]. Rye has been suggested to exert unique effects on 
postprandial insulin secretion, a phenomenon that has been named the “rye factor,” which 
will be discussed in detail later. Furthermore, rye has consistently been shown to increase 
subjective satiety and decrease hunger and desire to eat in the postprandial phase, which 
could be hypothesized to lead to weight loss and improved weight maintenance in a longer-


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2.2 Effect of rye consumption on body weight 
Due to its high fiber content and proposed satiety-enhancing effects, rye has been suggested 
to be superior to other cereals in generating weight loss [22]. One of the aforementioned 
meta-analyses included sub-group analyses to estimate the effects of individual cereals 
sources on body weight reduction [69]. No effect on body weight was found for rye, but at 
that time there were only two published studies reporting the effects of rye consumption on 
body weight [78, 89]. Both were cross-over studies with rather short intervention periods, 
which may not be optimal for evaluating changes in body weight. Since then, three additional 
studies have been published (Table 3.1) [59, 103, 108]. Two were similar to the previous 
studies, in the sense that they also followed a cross-over design, although one was of 8 weeks 
duration [59], where the others were 4 weeks [78, 89, 103]. Only one study used a parallel 
design [108]. This study included both a whole grain rye arm and a whole grain wheat arm, in 
addition to a refined wheat control arm, and could thus estimate the effects of whole grain 
per se and the effects of different sources of whole grain. This study was not designed to 
investigate weight loss. The participants were instructed to replace their habitual cereal 
products with intervention products in an ad libitum manner, rather than fixed amounts, and 
did not receive any other dietary restrictions. Their weight was not controlled during the 
study. Thus, even though the study was not designed for weight loss, it allowed for 
fluctuations in weight that might be induced by increased satiety or satiation due to the 
intervention products. Despite the relatively short duration of the study (6 weeks), the 
participants in the whole grain rye group lost 1.1 kg on average, a finding which differed 
significantly from what was seen in the participants in the refined wheat group, who gained 
0.2 kg. The participants in the whole grain wheat group lost some weight (0.6 kg), but not as 
much as the participants in the whole grain rye group and the change in body weight did not 
differ significantly from that of the refined wheat group. This study suggested some degree 
of superiority of whole grain rye in inducing weight loss that was not solely explained by the 
fact that participants ate whole grain. These results should be interpreted with caution since 
the study was not designed to analyze weight loss and was of a relatively short duration and 
small size. However, this study did support the hypothesis that rye may have some unique 
properties that are beneficial for body weight management. 
An effect of rye on body weight could, as mentioned above, be mediated through increased 
satiety, decreased hunger and lower subsequent energy intake, which will be discussed in 
detail later. It could also be influenced by other factors, such as fecal energy excretion or 
increased energy expenditure [107, 111]. Dietary fiber from cereals has been shown to bind 
nutrients in the GI tract and prevent absorption, which means that some of the energy 
consumed is excreted in the feces [107]. This could contribute to a negative energy balance, 
which would lead to body weight reduction. 
In recent years, the gut microbiota has emerged as a potential mediator of weight loss 
induced by fiber-rich diets and it has been suggested that some of the inter-individual 
variations in weight loss in response to a fiber-rich diet may be explained by differences in the 
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gut microbiota composition [24, 112–114]. A post hoc analysis of the previously mentioned 
study that found reduction in body weight in response to a whole grain rye diet showed that 
the weight loss in response to the whole grain-based diets correlated with abundance of 
Prevotella and that participants with high abundance of Prevotella lost more weight than 
participants with low abundance [24]. However, the whole grain rye and the whole grain 
wheat groups were pooled for the post hoc analysis, so it is unknown if these correlations 
differed between the cereal sources. Obesity has been associated with lower abundance of 
Bifidobacteria and animal studies have indicated that supplementation with Bifidobacteria 
might have anti-obesogenic effects [115–118]. Whole grain consumption has been associated 
with increased abundance of Bifidobacteria [119, 120] and a recent study indicated that 
whole grain rye is superior to whole grain wheat in its ability to increase the abundance of 
Bifidobacteria [59, 121]. 
 
3.3 Appetite 
The concept of appetite is complex and encompasses a range of different factors that directly 
or indirectly affect our eating behavior, thus having implications for body weight regulation 
[122]. Food intake is controlled by both physiological cues, such as stomach distension and 
appetite-regulating hormones, and psychological cues, such as liking specific foods, which 
may overrule physiological cues. The physiological concept of appetite has been summarized 
in the so-called satiety cascade, which was first described by Blundell in 1987 [123] (Figure 
3.1). This distinguishes between satiation, which can be described as the physiological cues 
that determine when we stop eating, and satiety, the physiological cues that appear between 
meals and determine when we start our next meal. In postprandial appetite studies, appetite 
often refers to satiety or fullness, hunger and desire to eat, but can in some cases also cover 
aspects such as prospective food intake, satisfaction and preoccupation with food [124]. The 
exact wording of questions related to these aspects may vary depending on which language 
a study is conducted in. For instance, the words satiety and fullness sometimes appear to be 
used interchangeably in English, whereas they can have distinct meanings in other languages.  
Satiation is to a large extent dependent on gastric distension, which occurs as we eat and fill 
up the stomach [125]. Gastric distension is affected by several factors, such as the volume 
and viscosity of the food consumed, as well as the gastric emptying rate [126]. A reduced 
gastric emptying rate extends the time of gastric distension as well as the time for digestion 
and absorption in the small intestine and can affect the release of gut peptides involved in 
appetite regulation [127]. Some of the most important gut peptides related to satiety and 
appetite are glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), peptide YY (PYY) and 
ghrelin [126]. CCK is released in response to the presence of fat or protein in the duodenum 
and is thereby involved in the early response to food intake, i.e., satiation. GLP-1 is produced 
in the small intestine, primarily in response to the presence of fat and carbohydrate, and is 
thought to play an important role in the so-called ileal brake, which is involved in the control 
of gastric motility and release of satiety-regulating hormones [126]. GLP-1 is a well-
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established pharmaceutical target for treatment of type-2 diabetes due to its ability to 
stimulate insulin secretion from pancreatic beta cells, and has in recent years received 
attention as a potential anti-obesity drug due to its appetite-suppressing capability [128–
130]. Ghrelin is an orexigenic hormone that decreases immediately after a meal and increases 
during the postprandial period [131]. Ghrelin has been shown to correlate with subjective 
hunger ratings and is likely involved in the initiation of an eating occasion [132, 133]. 
While decreased appetite is often considered an immediate postprandial response to a meal, 
the effect may extend over several meals, a phenomenon often referred to as the second 
meal effect. This phenomenon is believed to be mediated through production of short chain 
fatty acids (SCFAs), i.e., acetate, propionate and butyrate, that are produced through colonic 
fermentation of dietary fiber [134]. SCFAs have been shown to stimulate secretion of PYY and 
GLP-1 in animal and in vitro studies [135, 136]. This has been confirmed, to a certain extent, 
in mechanistic studies in humans [137, 138], though the implications of these findings on 
appetite regulation and food intake remain to be tested.  
 
 
Figure 3.1: The satiety cascade. Reproduced from Blundell et al. 2010 [139] with permission from John 




3.3.1 Effects of rye consumption on appetite 
The satiety-enhancing effects of rye-based products have been well investigated. Acute meal 
studies have been conducted where subjective appetite has typically been measured at 
regular time intervals following one or several meals. In these studies, subjective satiety has 
often been measured by participants rating their sense of fullness, hunger and desire to eat 
on a visual analogue scale (VAS) anchored with extreme sensations (e.g., “not hungry at all” 
and “extremely hungry”). Some studies complement this with postprandial blood sampling to 
measure the concentration of satiety hormones and some studies include an ad libitum meal 
to evaluate whether differences in appetite response translate into differences in subsequent 
energy intake. 
Table 3.2 summarizes randomized cross-over studies investigating subjective appetite 
response to various rye-based products. The majority of the studies found an improved 
appetite response after intake of rye-based products compared with control products [140–
149]. The rye products included various breads, crisp breads, porridges, kernels and pasta and 
the rye ingredients varied from sifted rye flour to intact rye kernels. In most cases, the rye 
products were based on whole grain rye, while the control products were often based on 
refined wheat. This is likely a reflection of the typical rye and wheat products available to 
consumers in the countries where the studies were conducted [150, 151] and attempts to 
study replacement effects aligned with the dietary guidelines. However, the comparisons do 
give rise to the question of whether the results can be attributed to rye per se or are due to 
other factors, such as dietary fiber.  
The results regarding energy intake in a subsequent ad libitum meal are inconsistent. Two 
studies reported a lower energy intake in participants consuming a rye-based breakfast meal 
[142, 146], while three studies found no difference in energy intake [140, 147, 152]. It is worth 
noting that two studies that found no effect on energy intake included a standardized lunch 
meal (second meal) before the ad libitum meal, meaning that the time between the rye-based 
meal and the ad libitum meal was longer than in studies not including a standardized lunch 
meal (480 vs. 240–270 min). This could indicate that a rye-based meal can reduce the energy 
intake in a subsequent meal, but its effects do not extend to the meal after that. 
Results regarding the second meal effect on appetite response are also unclear. Two studies 
included in Table 3.2 reported that differences in appetite following a rye-based breakfast 
extended beyond the second meal [141, 144], whereas other studies did not find this [145, 
152]. Assessment of the second meal effect often uses the so-called “evening design,” where 
participants consume a test meal for dinner and a standardized breakfast meal (the second 
meal) on the next morning, followed by postprandial appetite assessment. Also with this 
study design, results reported in the literature are inconsistent. Sandberg and colleagues 
conducted a series of studies, of which two studies showed an improvement in appetite 
response in the morning after a rye-based evening meal, compared with after a wheat-based 
evening meal [153, 154], though one study using a rye bread with added resistant starch did 
not confirm this [155]. Lastly, a study from the University of Copenhagen tested the second 
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meal effect following evening meals with refined grain wheat bread, whole grain rye bread or 
rye kernels, but found no effect on subjective appetite the following morning [156].  
Though the satiety-enhancing effects of rye-based products has been relatively well studied, 
no studies have investigated the satiating effects of rye-based products. One study examined 
the satiating effect of whole grain wheat pasta compared with refined wheat pasta, by having 
participants consume ad libitum meals containing the two types of pasta [157]. The 
hypothesis was that the whole grain-based pasta would induce increased satiation during the 
meal and lead to the participants consuming less energy. However, no such difference in 
energy intake was found in this study [157]. More studies are needed to understand the 
potential satiating effect of rye and other cereal-based foods and the link to satiety and 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   























   
   
   












































   
   
   


































   
   
   
   
 
   
   
   
   





   
   
   
   

































   
   
   
   



































































































































































































































































































































































































































































































   
   
   

























   
   
   




























   
   
   















































   
   
   


























   
   
   




























   
   
   




























































































































































































































































































































































































































































































































































































































































































































































































































































   
   




























   
   




























































































































































































































































































































































































































































































3.3.2 The link between appetite regulation and long-term weight management 
While a consistent effect of rye-based foods and other whole grain products on subjective 
appetite has been demonstrated in acute study settings and a consistent association between 
whole grain intake and body weight has been found in observational studies, the mechanistic 
link between the acute effect of specific food items on appetite and long-term weight 
management remains unproven. As previously mentioned, appetite regulation and food 
intake are results of activities in a complex system that involves both physiological and 
psychological factors and the ability of a food item to produce increased satiety response in 
a controlled setting may not translate into long-term reductions in food intake [161]. Indeed, 
the results on subsequent ad libitum food intake following consumption of rye-based 
products are inconsistent, despite a rather clear satiety-enhancing effect of rye-based 
products (Table 3.2). However, a recent meta-analysis of studies evaluating long-term weight 
change (≥ 8 weeks) following exposure to food items that have been shown to enhance satiety 
found evidence for a link between intake of such food items and long-term weight 
management, which indicates a link to energy intake [23]. In order to establish a causal link 
between satiety-enhancing foods and long-term weight loss, appetite assessment should be 
included in large-scale weight loss studies. However, the commonly used methods for 
appetite assessment are relatively resource-demanding and there is a need for development 
of new approaches to appetite assessment adapted for large-scale studies.  
 
3.4 Rye, metabolic risk factors and NCD risk 
In addition to the potential link between rye consumption, appetite regulation and body 
weight management, rye has been linked to several other beneficial health effects such as 
reduced postprandial insulin [158], reduced cholesterol [59, 162] and reduced levels of low-
grade inflammation [163]. 
Table 3.1 shows that many studies have investigated the effect of cereal intake, especially 
oats, on blood lipids. It is well established that beta-glucans, present in high amounts in oats 
and barley, have a lipid-lowering effect at intakes ≥ 3 g per day and the European Commission 
has authorized health claims on the matter [164–167]. The mechanism behind the effect of 
beta-glucans on blood lipids is believed to be dependent on binding of cholesterol in the 
intestine, reducing the re-uptake of cholesterol through the high viscosity of the beta-glucans 
[168]. While rye does not contain large amounts of beta-glucans, it does contain a rather large 
amount of soluble arabinoxylans which could be hypothesized to exert a similar effect on 
blood lipids [22]. Leinonen et al. found that rye bread reduced both total and low density 
lipoprotein (LDL) cholesterol and found indications of a higher intake of rye leading to a larger 
decrease in cholesterol levels [78]. On average, the rye breads included in the study by 
Leinonen provided 3–4 g of soluble fiber per day, which is similar to the amount of soluble 
beta-glucans considered to have a meaningful effect on blood lipids [164]. A recent study 
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found indications of a lipid-lowering effect of whole grain rye, but not whole grain wheat, in 
males with metabolic syndrome, which may be attributed to the higher amount of soluble 
viscous arabinoxylans in rye, whereas the fiber in wheat is to a larger degree insoluble [59].  
Rye has been suggested to have unique effects on postprandial insulin, a phenomenon that 
has been termed the “rye factor” [22]. The rye factor is characterized by a lowering of the 
insulin response, without corresponding lowering of glucose, which could indicate an 
improved insulin economy from consuming rye products [22]. However, in a recent review of 
the literature on the topic, we concluded that the phenomenon may be attributed to 
structural properties typical of, but not limited to, rye breads, rather than rye per se [Iversen 
et al., submitted]. This effect is thought to be mediated by several different factors, such as 
lower gastric emptying rate and digestion and absorption of glucose, which lead to a slower 
influx of glucose in the blood stream and reduced need for insulin [17, 169–171]. 
Whole grain and – to some extent – cereal fiber have shown an inverse association with risk 
markers of type-2 diabetes, such as fasting glucose and HbA1c, as well as with reduced risk of 
developing type-2 diabetes [17, 39, 172, 173]. Table 3.1 shows that several studies had risk 
markers related to diabetes, such as insulin sensitivity and glucose tolerance, as their primary 
outcome [59, 79, 91, 100–103, 110]. However, the results were mixed and the two studies 
investigating rye-based products found no major effects on fasting or postprandial insulin or 
glucose [59, 103]. More studies are needed to understand the potential effects of rye 







4.1 Hypotheses and research strategy 
Based on suggestive evidence from previous studies, a central hypothesis in this thesis was 
that consumption of rye-based cereal foods, with whole grains or fractions rich in dietary 
fiber, could have beneficial effects on body weight and metabolic risk markers. Furthermore, 
it was hypothesized that this effect might be mediated by mechanisms related to appetite 
regulation and gut microbiota.  
To investigate the effects of rye-based cereal foods on weight loss, a 12-week randomized 
controlled intervention specifically designed for this purpose was conducted (Paper I). In this 
study, assessment of appetite was conducted, and fecal samples were collected to investigate 
the potential links to the main outcomes and various metabolic risk markers were measured 
(Papers I and II). However, as metabolic risk markers are influenced by weight loss, a study 
designed for weight loss is not optimal for investigating the effect of rye consumption on 
metabolic risk markers. Therefore, data were included from a 12-week randomized parallel 
intervention study, in which metabolic risk markers in the context of weight stability were 
measured (Paper III). Lastly, a randomized cross-over study investigating the acute appetite 
response to rye breads with differing amounts of sourdough was conducted. As sourdough is 
a common ingredient in commercially available rye breads, it was relevant to investigate how 
this may influence factors believed to be involved in the effect of rye on health (Paper IV). 
Furthermore, the methodology used in this study was somewhat different from the 
methodology used in the weight loss study and could highlight some challenges and 
opportunities in the field of appetite assessment. An overview of the studies, as well as their 





Table 4.1: Overview of the studies included in the thesis. 
 Papers I and II 
(the RyeWeight study) 
Paper III 
(the RyeClaim study) 
Paper IV 
(the Sourdough study) 
Design 12 week, 2-armed, 
parallel, randomized,  
n = 242 
12 week, 2-armed, 
parallel, randomized,  
n = 182 
Single meal, 6-armed, 
cross-over, randomized, 
n = 23 
Inclusion 
criteria 
Males and females  
30-70 years 
BMI 27-35 kg/m2 
Males and females 
20-70 years 
50% with BMI ≤24 kg/m2 
and 50% with BMI>24 
kg/m2 
Males and females  
20-70 years 
BMI 18-25 kg/m2 
Intervention High fiber rye-based 
cereal products vs. 
refined wheat cereal 
products in a hypocaloric 
context 
High fiber rye-based 
cereal products with 
fermented rye bran vs. 
refined wheat cereal 
products in the context 
of habitual diet 
Breads with varying 
amounts of whole grain 
rye and sourdough, 
compared with refined 












metabolic risk markers, 
gut microbiota 
composition 





Objectives: A, B, C, D 
It was hypothesized that 
high fiber rye would lead 
to a larger decrease in 
weight loss and fat loss, 
as well as improvements 
in metabolic risk factors, 
and that such effects 
could potentially be 
associated with appetite 
ratings and gut 
microbiota.  
Objective: D 
It was hypothesized that 
high fiber rye products 
with fermented rye bran 
consumption would lead 
to improvements in 
metabolic risk markers. 
Objective: B 
It was hypothesized that 
increasing the amounts 
of sourdough and whole 
grain rye would lead to 
improved appetite 





4.2 Study designs and study populations 
4.2.1 The RyeWeight study 
Papers I and II are based on the RyeWeight study, a parallel, randomized, intervention study 
designed to investigate the effects of whole grain rye-based foods on body weight and body 
fat reduction, compared with those of refined wheat-based foods. The study began with a 2-
week run-in period where all participants consumed the wheat-based foods, followed by a 
12-week parallel phase where participants consumed either rye products or wheat products. 
During all 14 weeks, participants received guidance from a dietician to reduce energy intake 
and induce weight loss. The participants underwent a clinical examination three times during 
the 12-week intervention, at week 0, week 6 and week 12. The primary outcomes of the study 
were body weight, measured on a digital scale, and body fat percentage, measured using dual 
energy x-ray absorptiometry (DXA). The study was conducted in Uppsala, Sweden. 
The participants included in the RyeWeight study were adults aged 30–70 years with 
overweight or obesity (BMI 27–35 kg/m2). Participants were excluded if they had thyroid 
disorders, type-1 diabetes, history of major GI surgery or chronic GI conditions. Furthermore, 
people using nicotine products, antidiabetic drugs or anti-obesity drugs were not allowed to 
participate in the study. Additionally, participants were required to lose at least 0.5 kg during 
the 2-week run-in period to be randomized to the 12-week parallel phase. Figure 4.1 depicts 
the flow of participants through the study, with 317 participants starting the run-in phase and 
242 of them being randomized to the 12-week parallel phase. During the parallel phase, 14% 
of the participants dropped out of the study, with the main reasons for dropout being related 
to difficulties consuming the diet and logistical challenges in fitting study activities into 





Figure 4.1: Flowchart of participants in the RyeWeight study (Papers I and II). 
 
4.2.2 The RyeClaim study 
Paper III was based on the RyeClaim study, which was designed to investigate the effects of 
whole grain rye products with added fermented rye bran on Helicobacter pylori infection. A 
range of metabolic risk markers were measured as secondary outcomes, which were the focus 
of this thesis. The RyeClaim study was designed as a 12-week parallel intervention where 
participants were randomized to consume either whole grain rye-based products with added 
fermented rye bran or refined wheat products for the entire 12-week period. In addition, the 
participants were invited to a follow-up examination 12 weeks after completing the 
intervention period (week 24). The study was conducted in Shanghai, China, where the 
background diet is low in whole grains and particularly low in rye.  
As the study was designed to investigate the effect on Helicobacter pylori infection, all 
participants were tested for Helicobacter pylori during the screening and a positive test was 
a requirement for enrollment. Furthermore, participants with active ulcers were excluded. 
Use of antibiotics or treatment for Helicobacter pylori infection were considered concomitant 
medications and participants using such during the intervention period were not included in 
the data analysis. The participants were 20–70 years of age and 50% were overweight (BMI ≥ 
24 kg/m2), while the rest were normal weight (BMI < 24 kg/m2). Smoking or use of medication, 
except antihypertensives, were reasons for exclusion. In total, 182 participants were enrolled 
and randomized, of which 161 completed the 12-week intervention. Three of those 
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participants were excluded from further analysis due to use of concomitant medication during 
the study, meaning that 158 participants were included in the analysis (Figure 4.2). The main 
reasons for drop-out were related to travel plans interfering with study participation.  
 
 
Figure 4.2: Flowchart of participants in the RyeClaim study (Paper III). 
 
4.2.3 The Sourdough study 
Paper IV was based on a randomized, 6-armed, cross-over study designed to investigate the 
acute effect of breads with varying amounts of sourdough and rye, compared with refined 
wheat bread, on subjective appetite. Sourdough is a common ingredient in rye bread and has 
been hypothesized to influence appetite response. Therefore, this study aimed to investigate 
the effects of sourdough and rye on appetite response. The participants in the study 
consumed six test breads (five sourdough rye breads and one wheat bread) as part of a 
breakfast meal on six separate occasions and recorded their subjective appetite for 4 hours 
following this meal. The study was conducted in Uppsala, Sweden. The participants were aged 
20–70 years, non-smokers with low to moderate physical activity level. In total, 23 
participants were included in the study and all of them completed all six test occasions.  
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4.2.4 Sample size estimation of studies 
The sample size for the RyeWeight study was based on a complete case analysis of the two 
primary outcomes: body weight and body fat percentage. Bonferroni adjustment was applied 
to account for having two primary outcomes and therefore alpha was set to 2.5%, with a 
power of 80%. It was determined that 106 complete cases would be needed in each group to 
detect a 1 kg difference in body weight (standard deviation 2.4 kg) and 1% difference in fat 
percentage (standard deviation 1.5%). To allow for drop-out rate of up to 18% the inclusion 
target was 260 participants. The RyeClaim study had a single primary outcome, for which 
reason the power was set to 80% and alpha to 5%. Based on data from an unpublished pilot 
study, it was theorized that a 30% decrease in Helicobacter pylori load could be of clinical 
relevance. To allow for a 20% drop-out rate, the plan was to include 90 participants in each 
group. No formal power calculation was conducted for the Sourdough study; instead, based 
on previous experiences [148, 149, 152] and power calculations done by Flint et al. [174], it 
was estimated that 20 complete cases would be needed to enable detection of a difference 
of 10 % in satiety ratings between treatments. 
 
4.3 Intervention diets 
4.3.1 The RyeWeight study 
The intervention products in the RyeWeight study consisted of breakfast cereals, crisp bread 
and soft bread, in both the rye group and the wheat group (Table 4.2). Breakfast cereals 
consisted of extruded rye and wheat puffs, as well as rolled rye flakes and semolina wheat, 
packed in 30 g servings. Participants were instructed to consume two packages per day, but 
could choose freely if they wanted puffs or flakes/semolina. Participants in the rye group had 
four different rye crisp breads to choose from and were instructed to consume 4–6 slices per 
day (due to a difference in slice weight between the varieties). The wheat group had only one 
type of crisp bread and were instructed to consume 5 slices per day. Crisp bread was packed 
in servings to help participants consume correct amounts and make it easier to take products 
with them when eating away from home. Frozen soft bread was provided to the participants, 
who were instructed to eat one serving per day. Participants were given the choice of 
different breakfast cereal and crisp breads in order to provide some variation that might 
facilitate compliance and to mimic a real-life setting where people may choose different 
products depending on their preference. 
Participants were instructed not to consume any other cereals than the ones they received 
from the study, although very small amounts of “hidden” cereals (e.g., sauce thickener) were 
permitted. The participants filled out a pre-coded compliance journal every day during the 
study, where they ticked all products they had consumed. Further, participants were 
instructed to also note down any deviations from the intervention diet, changes in habitual 
medication, or any illness in the journal. Furthermore, the participants received guidance 
from dieticians to reduce energy intake and induce weight loss. The dietary guidance followed 
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a modified version of the Step-wise Weight-determined Accumulative Change Plan (SWAP 
model) developed by Bertz et al. [175]. The model aims to change each participant’s diet in a 
prioritized step-wise approach by implementing one or more of the following steps: 1) 
minimizing the intake of sweets, 2) minimizing the intake of fast food, 3) choosing “keyhole” 
marked products, 4) increasing intake of vegetables and 5) decreasing serving sizes. The aim 
was to reduce participants’ energy intake to an energy deficit of 500 kcal/day, while 
maintaining an energy source distribution as recommended in the Nordic Nutrition 
Recommendations [176]. Each participant had an individual meeting with the dietician when 
initiating the run-in period and was thereafter contacted by the dietician by email or phone 
approximately 2–3 weeks after their clinical examination in week 0 (4–5 weeks after initiating 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.2 The RyeClaim study 
The intervention products used in the RyeClaim study consisted of whole grain rye crisp bread 
and whole grain rye extruded breakfast cereals with added fermented rye bran (25% 
weight/weight of dry ingredients). The rye bran was fermented through a patented process 
which involves fermentation with Lactobacillus plantarum (DSMZ 13890). Supernatant from 
the fermented rye bran has been shown to reduce in vitro adherence and colonization of 
Helicobacter pylori and to reduce the bacterial load in a small pilot study in humans 
(unpublished data), which was the rationale behind testing the effect of this type of bran 
product on Helicobacter pylori infection in humans on a larger scale. The control group 
received corresponding crisp breads and extruded breakfast cereals consisting of refined 
wheat. Participants were instructed to consume a fixed amount of products per day, but were 
allowed to consume their habitual diet without other restrictions (Table 4.3). 
Table 4.3: Nutritional composition of the products included in the RyeClaim study (Paper III). The 


















Whole grain rye products with fermented rye bran 
Crisp bread 44.8 145.5 4.3 1.2 23.9 11.1 3.2 1.2 
Puffs 110.0 372.6 11.4 3.3 61.2 26.3 5.0 2.8 
Sum 154.8 518.1 15.7 4.5 85.1 37.4 8.2 4.0 
Refined wheat products 
Crisp bread 58.8 210.5 6.8 1.0 41.2 3.6 4.5 1.1 
Puffs 84.0 302.7 9.7 1.6 58.1 8.6 4.9 1.4 
Sum 142.8 513.2 16.4 2.6 99.3 12.2 9.4 2.3 
 
4.3.3 The Sourdough study 
The five sourdough rye breads included in the Sourdough study varied in the amount of 
sourdough (9, 30 or 51% of dough weight) and rye flour (35, 42 or 48% of dough weight) (Table 
4.4). The sourdough consisted of 40:60 whole grain rye flour:water and the flours used for 
the breads were whole grain rye flour and refined wheat flour. The amount of sourdough was 
high in the breads with 51% sourdough, compared to most commercial rye breads [151]. 
The breads were served as part of a breakfast meal containing 100 g bread, 15 g margarine, 
20 g cheese, 100 g orange juice and 150 g coffee, tea, or water. Participants stated their 
preference of coffee, tea, or water on the first occasion and were served the same beverage 







Table 4.4: Composition, nutritional values, pH and acids of breads used in the Sourdough study 
(Paper IV). Values are grams per serving (100 g of bread) unless otherwise stated. 
 MS/MR HS/LR HS/HR LS/LR LS/HR Refined wheat bread 
Sourdough/rye (% 
of dough weight) 
30/42 51/35 51/48 9/35 9/48 0/0 
Rye (g) 27 23 30 23 30 0 
Protein (g) 7.1 7.2 6.9 7.3 6.3 7.5 
Fat (g) 2.2 2.2 2.2 2.2 1.9 3.9 
Starch (g) 41.2 41.9 39.9 40.4 39.8 41.9 
Total fibera (g) 7.0 6.0 7.2 6.8 8.3 3.6 
Soluble fiber (g) 2.3 2.0 2.5 2.1 2.7 1.6 
Insoluble fiber (g) 4.7 4.0 4.7 4.7 5.5 3.0 
Ash (g) 1.7 1.6 1.7 1.7 1.5 1.4 
Water (g) 35.0 35.7 36.1 35.8 35.7 38.0 
Energy (kJ)b 959 963 934 946 920 992 
pH 4.4 4.2 4.2 5.2 5.3 5.0 
Lactic acid (g) 0.81 0.81 0.89 0.4 0.36 0.27 
Acetic acid (g) 0.13 0.14 0.16 0.07 0.04 0.04 
a Fiber content as analyzed using the Uppsala method with inclusion of fructans. 
b Energy content was calculated using a conversion factor of 37 kJ/g for fat, 17 kJ/g for proteins and 
starch and 8 kJ/g for fiber.  
Abbreviations: MS/MR, medium sourdough/medium rye; HS/LR, high sourdough/low rye; HS/HR, 
high sourdough/high rye; LS/LR, low sourdough/low rye; LS/HR, low sourdough/high rye. 
 
4.3.4 Blinding 
Blinding is generally a challenge in dietary interventions, as it is often difficult to conceal from 
the participants what they are consuming. This was the case in the studies included in this 
thesis. In the RyeWeight and the RyeClaim studies, intervention products were packed in 
neutral packaging and marked with neutral codes. However, due to the visual difference 
between rye and wheat products, it is likely that the participants were able to guess their 
allocation. In the Sourdough study, the rye breads looked relatively similar, and the 
participants were not aware that the breads differed in rye and sourdough content. However, 
the wheat bread still differed visually from the rye breads.  
The research staff conducting physical examinations and collecting samples from the 
participants in the RyeWeight and the RyeClaim study were not aware of the participants’ 
allocation. The participants in the RyeWeight study had their initial consultation with the 
dietician before randomization, but it is likely that some participants revealed their allocation 




4.4 Outcome assessment 
4.4.1 Clinical examinations 
In both the RyeWeight and the RyeClaim studies, participants underwent a clinical 
examination in week 0, week 6 and week 12 after an overnight fast. In the RyeClaim study, 
the examination was repeated in week 24. 
In the RyeWeight study, body weight was measured on a digital scale with the participant 
wearing light clothing, after which waist and hip circumferences, as well as sagittal abdominal 
diameter, were measured. Blood pressure was measured with an automated blood pressure 
meter when the participant had been resting in a supine position for 10 minutes, after which 
venous blood samples were collected. Participants underwent a full body DXA scan to 
determine body composition, and filled out questionnaires regarding physical activity and GI 
symptoms. 
In the RyeClaim study, participants had a 13C-urea breath test to determine the bacterial load 
of Helicobacter pylori, had their weight and body composition measured on a digital 
bioimpedance scale and had venous blood samples drawn. A subgroup of participants 
underwent a DXA scan to validate the body fat percentage measured with the bioimpedance 
scale. 
 
4.4.2 Appetite assessment 
Subjective appetite was measured in both the RyeWeight study and the Sourdough study, but 
the methodology differed between the two studies. 
In the Sourdough study, a “traditional” clinic-based appetite assessment was used, where 
participants arrived at the research facility in the morning after an overnight fast, answered 
questions about their appetite and immediately thereafter consumed a breakfast meal. Then, 
the participants answered questions about their appetite every 30 min for 4 hours. After 4 
hours, participants were served an ad libitum meal and were asked to eat until comfortably 
full. The amount of food eaten was recorded to assess whether the food intake at lunch 
differed depending on the breakfast meal. Between breakfast and lunch, participants could 
occupy themselves with sedentary activities, such as working on a laptop.  
The RyeWeight study had ten times more participants than the Sourdough study, meaning 
that it was not practically possible to conduct clinic-based appetite assessments. Instead, we 
designed a protocol for a home-based appetite assessment, where participants conducted 
the appetite assessment outside the clinical setting. The participants were provided with a 
standardized meal plan for all meals of the day, as well as a detailed schedule of when to 
consume which meals and when to answer questions. The meal plans included all meals – 
breakfast, lunch, dinner, and snacks – with intervention products according to randomization 
included in the meals. The amounts of food were adjusted to match each participant’s energy 
needs under the hypocaloric conditions which they were generally advised to follow during 
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the study. All the food needed for each day was provided to the participants. Participants 
answered questions about their appetite every 30 min from right before breakfast (8:00) until 
right before lunch (12:00) and then once every hour from 13:00 to 22:00. The participants 
had dinner at 18:00 and snacks at 15:00 and 20:00. 
The questions used to evaluate appetite were the same in both studies. At each time point, 
participants answered three questions in random order: “How hungry are you?”, “How full 
are you?”, “How strong is your desire to eat?”. Questions were answered on a 100-point VAS 
with the following words anchored at each end: “Not hungry at all/I have never felt more 
hungry,” “Not full at all/Extremely full” and “Not strong at all/Extremely strong”. In the 
Sourdough study, participants answered the questions on hand-held minicomputers that 
automatically notified them when it was time to answer questions. In the RyeWeight study, 
an online survey tool was used to send an email with a link to the questionnaire when it was 
time to answer questions. In both cases, questionnaires were available on paper, in case of 
technical difficulties. 
 
4.4.3 Dietary assessment 
Dietary intake was measured in the RyeWeight study before the start of the intervention, 
before the week 6 clinical visit and before the end of the intervention. On each occasion, 
participants were instructed to complete a 3-day weighed food record. Energy and 
macronutrient intakes were calculated by a dietician using the software Dietist Net Pro which 
contains a brand-specific database adapted for use in Sweden. Additionally, intake of foods 
from different food groups was summarized using the same method as in the national dietary 
intake survey conducted by the National Food Agency of Sweden, “Riksmaten” [177]. 
 
4.4.4 Clinical chemistry 
Laboratory work was not included in the thesis work and is described in detail in the papers; 
it will be described only briefly here. 
In the RyeWeight study, blood samples were kept on ice during sampling and were 
centrifuged and aliquoted immediately after sampling before being stored in a biobank at -80 
°C until analysis. Once all participants had completed the study, blood samples were sent to 
the Department of Clinical Chemistry at Uppsala University Hospital for analysis. Insulin was 
measured in serum, while glucose, C-reactive protein (CRP), triglycerides, total cholesterol, 
high-density lipoprotein (HDL) cholesterol and LDL cholesterol were analyzed in sodium 
heparin plasma. SCFAs were measured in heparin plasma using a method developed at 
Chalmers University of Technology [manuscript in preparation]. Alkylresorcinols (AR) were 
measured in EDTA plasma as a supporting measure of compliance at Chalmers Mass 
Spectrometry Infrastructure, using a method developed there [178]. The fasting blood 
samples collected in the RyeClaim study were sent to the laboratory at the Zhongye Hospital 
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in Shanghai immediately after collection and were analyzed for selected metabolic risk 
markers. Remaining sample materials were stored in a study biobank at -80 °C and were later 
analyzed for AR as a marker of compliance in sample extracts taken to the Swedish University 
of Agricultural Sciences for analysis.  
In both the RyeWeight and the RyeClaim studies, total AR was calculated as a biomarker of 
whole grain intake from rye and wheat sources, while the AR C17:0/ C21:0 homologue ratio 
was calculated as marker of the proportion of whole grain from wheat and rye sources. Since 
the C17:0 homologue is primarily present in rye, a higher ratio of C17:0/C21:0 indicates that 
a larger proportion of the consumed whole grain cereals are from rye, while a low ratio 
indicates that the intake is primarily from wheat [179]. 
 
4.4.5 Gut microbiota composition 
Participants in the RyeWeight study collected fecal samples at week 0, week 6 and week 12. 
Participants were provided a feces collection kit and were instructed to store the fecal 
samples in a cooling bag with frozen cooling blocks for up to 24 hours before delivering the 
sample to the clinic, or alternatively store the fecal sample in their household freezer for up 
to 3 days before transporting it to the clinic in the cooling bag. Samples were stored in the 
study biobank and after completion of the study, the microbial composition were analyzed 
using 16S ribosomal RNA at the Swedish University of Agricultural Sciences, as described in 
paper II. 
 
4.4.6 Data analysis 
Statistical data analysis in the RyeClaim study was performed using R Studio, while data from 
the RyeWeight study and the Sourdough study were analyzed using SAS statistical software. 
In addition, some figures were created using GraphPad Prism.  
The RyeWeight and RyeClaim studies were both randomized, parallel studies and analysis 
strategy was to compare the two groups at week 6 or week 12, adjusting for baseline (week 
0). Analyses of metabolic risk markers were adjusted for change in weight, which is known to 
affect such markers. The RyeWeight study was a weight loss study and participants lost 
weight, meaning that the results regarding metabolic risk factors were confounded by this. In 
addition to adjusting for change in body weight, correlations between changes in metabolic 
risk markers and changes in body weight were explored; however, confounding cannot be 
ruled out and results should be interpreted with care. The RyeClaim study was not designed 
for weight loss and there were no differences between the groups in terms of weight, but 
metabolic risk factors were not the primary outcomes of the study and some caution should 
be used when interpreting the results.  
The Sourdough study was a cross-over study, which means that each individual served as their 
own control. An advantage of such design is that it limits the effects of inter-individual 
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differences. However, it is not optimal for all studies due to the risk of carry-over effect, where 
the effect of one treatment period can affect the outcome of the following treatment period. 
Differences in appetite response depending on the breads consumed were analyzed using an 
analysis of covariance model with a repeated statement to consider the cross-over design. 
The models were adjusted for appetite response recorded right before breakfast (baseline) 
as the study was randomized and any differences between the participants’ appetite at 
baseline was assumed to be a result of random variation. This is in contrast to the appetite 
assessments made in the RyeWeight study, where participants had been consuming the rye 
or wheat products in the days leading up to the appetite assessment and any differences in 
appetite before breakfast may have been a result of their regular consumption of such 
products. It should also be mentioned that the RyeWeight study was not a cross-over study, 
which means that there has likely been a larger influence of inter-individual differences on 




5 RESULTS AND DISCUSSION 
 
5.1 Participants, background diet and compliance 
Detailed participant characteristics and information regarding diet, compliance and similar 
have been published in the papers and will be described briefly here. Table 5.1 shows the 
BMI, age and sex of the participants in the three studies. The RyeWeight and the RyeClaim 
studies had relatively large sample sizes, compared with many other whole grain 
interventions (Table 3.1), which was a strength of these studies. 
Table 5.1: Summary of participant characteristics across the three studies reported in Papers I, II, III 
and IV. 
 RyeWeight 





 Rye Wheat  Rye Wheat  All 
















5.1.1 The RyeWeight study 
Dietary records from the RyeWeight study showed that energy intake did not differ between 
the groups before or during the intervention, but in both groups the energy intake was 100-
150 kcal/day lower at week 6 and week 12 compared to the energy intake before the 
intervention (Paper I). The dietary fiber intake in the wheat group remained relatively stable 
throughout the intervention, whereas the dietary fiber intake increased in the rye group and 
was significantly higher than the intake in the wheat group at week 6 and 12 (approximately 
20 vs. 38 g/day, Paper I). The protein intake was slightly higher in the wheat group compared 
with the rye group in week 12, but otherwise the macronutrient intake did not differ between 
the groups. The physical activity level, assessed through questionnaires, was stable 
throughout the entire study period (Paper I). 
The compliance in the RyeWeight study was good, based on both self-reported product intake 
(94–95% of prescribed products were consumed on average) and plasma AR, which was used 
as a supporting biomarker of whole grain rye and wheat intake. In Figure 5.1, a clear 
separation between week 0 and week 6/12 can be observed in the rye group, while there is 
no separation in the wheat group, which is what would be expected in a compliant population. 
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Figure 5.1: Total plasma alkylresorcinols and the C17:0/C21:0 ratio for the participants in the refined 
wheat group (left) and the high fiber whole grain rye group (right) in the RyeWeight study. The red 
points are week 0, green points are week 6 and blue points are week 12. For clarity, two observations 
(one from each group) with C17:0/C21:0 ≥ 2 have been omitted from the panels. Notice the different 
axis ranges in the panels.  
 
5.1.2 The RyeClaim study 
Unfortunately, more limited background information was collected in the RyeClaim study and 
there were no data on background diets or physical activity levels. Compliance was measured 
through AR and showed an overall poor compliance to the intervention. Figure 5.2 shows that 
the total plasma AR does not separate the participants from the two groups as clearly as it 
did in the RyeWeight study. Many participants had C17:0, a marker of rye intake, below the 
detection limit at baseline, making it difficult to evaluate the change in C17:0/C21:0 ratio over 
time. The poor compliance could be related to the fact that the type of products used in the 
study are not commonly consumed in China and that rye has a distinct taste that may not be 
considered palatable in a Chinese population. However, it should also be noted that there is 
limited experience of using AR in Asian populations and the results should be interpreted with 
caution. The total AR concentration in the wheat group in the RyeClaim study was markedly 
lower than that in the wheat group in the RyeWeight study (2–4 nmol/l vs. 70–80 nmol/l). 
This could be related to a relatively lower pre-study exposure to AR, as cereals high in AR are 
consumed to a much lesser extent in China than in Sweden, with lower amounts accumulated 
in tissue and released into the blood. It has been shown that individuals consuming a gluten-
free diet, and therefore having a very low exposure to whole grain rye and wheat, have a very 
low AR concentration in the blood (< 27 nmol/l) [180]. It should also be mentioned that the 
samples from the RyeWeight study were analyzed using a liquid chromatography tandem 
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mass spectrometry-based method which has been shown to overestimate AR concentration 
in higher concentration range (> 150 nmol/l), compared with the gas chromatography mass 
spectrometry method that was used to analyze the samples from the RyeClaim study [178]. 
However, it is highly unlikely that this difference between the methods would explain the 20-
fold difference in concentration. There are very few studies reporting AR in Asian populations, 
but one cross-sectional study investigating the correlation between a specific AR metabolite 
and type-2 diabetes risk markers found markedly lower plasma concentrations of the specific 
metabolite in the Asian population compared with a European population, which is likely 
explained by a lower exposure to AR due to very low intake of whole grain wheat and rye 
[181]. Nonetheless, the compliance in the rye group overall was low. 
 
 
Figure 5.2: Total plasma alkylresorcinols for participants in the RyeClaim study. Red points are 
participants randomized to whole grain rye products with fermented rye bran and blue points are 
participants randomized to refined wheat products. 
 
5.1.3 The Sourdough study 
All participants in the Sourdough study completed all six test meals, except one participant 
who missed the ad libitum meal on one occasion. The participants were not subjected to any 
interventions or restrictions between the test occasions, so no measures of compliance or 
similar were included in this study. 
When examining the composition of the sourdough breads, we found that the organic acid 
content, which has been hypothesized to be involved in the mechanism behind improved 
appetite response following consumption of sourdough bread, was low compared with the 
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breads with added acid that have been used in several of the studies underlying the 
hypothesis [182–184]. The sourdough content in the breads used in the Sourdough study was 
high, up to 51% of dough weight, which produced a relatively sour tasting bread. 
Furthermore, the amount of acid is high when comparing with breads available on the 
Swedish market [151], and it seems unlikely that sourdough fermentation alone could 
produce the amount of acid in some of the studies using added acid to mimic the effect of 
sourdough fermentation [183, 184]. In conclusion, even though acid may influence appetite, 
it is unlikely that sourdough fermentation alone would produce enough acid to have a 
meaningful effect on appetite.  
 
5.2 Effect of rye consumption on body weight and body fat reduction 
The RyeWeight study showed that participants in the rye group had a lower body weight than 
participants in the wheat group after both 6 and 12 weeks of intervention (Figure 5.3). On 
average, the rye group lost 2.9 kg (of which 2.7 kg were fat) during the 12-week intervention, 
while the wheat group lost 1.8 kg (of which 1.8 kg were fat). The rye group had a lower body 
fat percentage at week 12 compared with the wheat group, though this difference was not 
significant after adjustment for multiple endpoints (p = 0.031, significance level: p < 0.025). 
Intention-to-treat analyses confirmed the difference between the groups in body weight and 
body fat mass, and the difference in body fat percentage was significant in the intention-to-
treat analyses, even after adjustment for multiple endpoints (Paper I).  
 
Figure 5.3: Differences between the rye group and the wheat group in terms of body weight and 
body composition in the RyeWeight study after 6 and 12 weeks of intervention. The rye group was set 
as the reference when calculating the difference between the groups, so if the bar reaches above the 
zero it means that the wheat group was higher than the rye group. * p < 0.050, ** p < 0.001. 
 
In the RyeClaim study, there were no differences between the groups in terms of body weight 
and body fat percentage (Paper III). As this was not a weight loss study, changes in weight 
were not expected. In fact, as no dietary restrictions were imposed on the participants in the 
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RyeClaim study, aside from them having to consume the intervention products, it is likely that 
the products were in some cases added to their habitual diet, rather than replacing other 
products.  
 
5.2.1 Potential mechanisms behind the effects of rye on body weight and body fat 
5.2.1.1 Appetite 
Figure 5.4 shows the appetite responses in the appetite assessments conducted in week 0, 
week 6 and week 12 of the RyeWeight study. Surprisingly, there were no differences between 
the groups in week 0 and week 12. At week 6, the rye group reported lower desire to eat, 
lower hunger and higher sense of fullness during the morning period, compared with the 
wheat group. Over the rest of the day, there were no difference between the groups at week 
6. The same was evident when comparing the area under the curve (AUC) (Paper I). There 
was a difference between the groups at week 6, when assessing AUC for the morning period 
(8:00-12:00), but there were no differences during the afternoon period (12:00-18:00) or the 
evening period (18:00-22:00), and no difference when assessing AUC for the whole day. There 
were no differences between the groups at week 0 or week 12. Correlations between appetite 
response and changes in body weight and body fat did not reveal any consistent correlations; 
thus, no indications of a link between subjective appetite response and changes in body 
weight and body fat in the RyeWeight study were found (Table 5.2). 
Previous studies showing a positive effect of rye on appetite response have been conducted 
in a clinical setting, where participants underwent most of the assessments in a research clinic 
under controlled conditions (Table 3.2). The RyeWeight study is one of the first studies to 
conduct appetite assessments at home, in a completely free-living setting. This means that 
participants have likely been exposed to more outside stimuli, such as seeing or smelling 
foods not included in the study, talking about food with colleagues and family, and similar 
things that participants in clinical settings are isolated from. While this has likely led to more 
variation or “noise” in the data, it has also allowed evaluation of the appetite response under 
more realistic, real-life conditions [139, 185]. It is important to remember that appetite 
response obtained under clinical conditions, where participants are isolated from many 
stimuli they would encounter in everyday life, cannot necessarily be directly transferred to 
real-life conditions, and extrapolation of results should therefore be done with caution [185]. 
Studies comparing subjective appetite under free-living conditions and under controlled 
settings could aid our understanding of this and help us develop a methodology suited for 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the Sourdough study, appetite assessments were conducted under more “traditional” 
conditions. Here, a difference was seen between the refined wheat bread and some of the 
sourdough rye breads, specifically the ones with high rye content, while there seemed to be 
no consistent pattern when looking at the sourdough content (Figure 5.5). This was apparent 
even though the range in rye content was relatively narrow, while the range in sourdough 
content was relatively wide. One could hypothesize that an even wider range in rye content 
might have resulted in a stronger effect of rye on appetite. Nonetheless, this study does 
support an effect of rye consumption on subjective appetite response. On the other hand, 
the findings from the RyeWeight study could indicate that the improvement in appetite 
induced by rye products under controlled conditions cannot be transferred to free-living 
conditions. However, there are also potential weaknesses in the design of the appetite 
measurements of the RyeWeight study, which could have influenced the results.  
While there were generally no differences between the groups in the RyeWeight study in 
terms of subjective appetite response, there were some indications of differences in 
subjective appetite response during the morning period at week 6. The fact that the 
difference was evident during the morning, and not later in the day, could be speculated to 
be related to the frequency of meals throughout the day. Participants consumed breakfast at 
8:00 and lunch at 12:00, leaving 4 hours between meals during the morning. During the 
afternoon and evening, the participants consumed prescribed meals every 2–3 hours, which 
might be too often to capture the potentially extended satiety induced by rye consumption. 
This is in line with observations made while conducting the study, where some participants 
stated that they felt that the meals were too frequent during the later parts of the day, leaving 
them little time to develop and experience a clear distinction between hunger and fullness. 
For future studies, it might be relevant to reconsider the number of meals during the appetite 
assessment, to capture a wider range of the postprandial state. Additionally, it was difficult 
for some participants to complete the entire appetite assessment, which was scheduled to 
finish at 22:00, as it was past their usual bedtime. Therefore, it might be advisable to finalize 
the assessment at an earlier time in future studies. 
Lastly, it should be mentioned that the participants in the RyeWeight study recorded appetite 
by use of an online survey tool. While this was popular among the participants, who found it 
very convenient to answer questions on their phones, computers or similar, the specific 
system used in this study has not been validated for appetite assessment. Traditionally, 
assessment of appetite response has been done on paper, but recently more studies have 
been conducted using various electronic systems. Some, but not all of these systems has been 
validated against paper questionnaires [186–188]. Based on participant feedback on the use 
of electronic questionnaires, such use should be encouraged in future studies. However, 






Figure 5.5: Appetite response in the Sourdough study. Abbreviations: AUC, area under the curve; 
HS/HR, high sourdough and high rye content; HS/LR, high sourdough and low rye content; LS/HR, low 
sourdough and high rye content; LS/LR, low sourdough and low rye content; MS/MR, medium 




5.2.1.2 Energy intake 
The Sourdough study included an ad libitum lunch meal, 4 hours after consumption of the 
breakfast meal. This showed that two of the rye breads resulted in lower energy intake. 
However, one bread had high rye content and the other low rye content, so this did not 
suggest that the amount of rye affected subsequent energy intake (Figure 5.6). It should be 
noted that both breads that resulted in lower energy intake were low in sourdough content, 
which adds to the notion that a high amount of sourdough does not have a positive effect on 
subjective appetite response or subsequent energy intake.  
 
 
Figure 5.6: Voluntary energy intake at the ad libitum lunch meal in the Sourdough study. 
Abbreviations: HS/HR, high sourdough and high rye content; HS/LR, high sourdough and low rye 
content; LS/HR, low sourdough and high rye content; LS/LR, low sourdough and low rye content; 
MS/MR, medium sourdough and medium rye content.  
 
No ad libitum meal test was included in the RyeWeight study, as the participants conducted 
the appetite tests outside the clinical setting. However, data from food records showed 
positive correlations between change in energy intake and changes in body weight and body 
fat, indicating that the weight loss was at least to some extent mediated by energy intake 
(Table 5.3). This is to be expected and does not give any indication as to whether the energy 
intake was, in turn, mediated by the intervention products. The energy intake did not differ 
significantly between the groups at any time during the intervention (Paper I). Food records 
are associated with uncertainties and should be interpreted with caution, but the lack of a 
difference in energy intake between the rye group and the wheat group may suggest that the 
difference in weight reduction may in part be rooted in other underlying mechanisms, such 
as fecal energy excretion and increased energy expenditure [107, 111]. Correlations between 
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plasma AR and changes in body weight and body fat did reveal inverse correlations between 
total AR, as well as C17:0/C21:0, and changes in body weight and body fat (Table 5.4). 
However, this was only evident when correlating data from all participants, irrespective of 
diet allocations, and may therefore be confounded by the fact that both changes in body 
weight and body fat and plasma AR differed between the groups. Correlation analysis within 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5.4: Correlations between change in body weight and body fat and plasma concentration of 
alkylresorcinols, a biomarker of rye and wheat intake, in the RyeWeight study. 
 All (n = 207) Rye group (n = 108) Wheat group (n = 99) 












































































































Data are correlation coefficients (p-values). Significant (p < 0.05) correlations highlighted in bold. 
 
5.2.1.3 Gut microbiota and SCFAs 
In the RyeWeight study, microbiota composition was analyzed and, as reported in Paper II, 
the intervention induced certain changes in the microbiota. Most notable was an increase in 
the fiber degrading Agathobacter and Prevotella in the rye group, although the latter did not 
differ significantly between the groups due to baseline differences. The increase in these 
bacteria was likely a response to the high amount of fiber in the rye products, as they are 
known to degrade fiber and have previously been associated with high fiber intake [189, 190]. 
Plasma butyrate concentration was higher in the rye group than in the wheat group after 6 
and 12 weeks of intervention (Paper II). This may be attributed to the increase in 
Agathobacter, as Agathobacter is known to produce butyrate [191]. Acetate differed between 
the groups after 6 weeks of intervention, but there were no additional effects of the 
intervention on plasma SCFA concentration (Paper II). 
Overall, there was no association between changes in gut microbiota composition and 
changes in body weight and body fat, aside from an inverse correlation between change in 
Holdemania abundance and change in body fat within the rye group (i.e., increasing 
abundance of Holdemania was associated with reduction in body fat). However, the 
abundance of Holdemania seemed to decrease over the course of the intervention in the rye 
group, which is counterintuitive. It appears that relatively little is known about the functions 
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of Holdemania in the human gut and its potential implications for human health. Different 
species and strains of Holdemania may have different effects in the human gut. The 16S rRNA 
methodology used in the RyeWeight study is limited to characterization on a genus level and 
a deeper characterization may be needed to understand the link between gut microbiota and 
physiological response to the dietary intervention. 
Previous studies have consistently found an association between Prevotella abundance at 
baseline and weight loss in response to a fiber-rich diet [24, 112, 113]. However, no such 
correlation was found in the RyeWeight study. On the other hand, baseline abundance of 
Lactococcus was seen to correlate negatively with changes in body weight and body fat in the 
rye group, while correlating positively with the same outcomes in the wheat group. It is 
important to note that the RyeWeight study included a run-in period and that the baseline 
fecal samples were collected towards the end of the run-in period and therefore may not 
reflect the participants’ gut microbiota composition before entering the study, since they 
were provided refined wheat during the run-in. Gut microbiota composition has been shown 
to change within days in response to dietary intervention, although the dietary interventions 
used in those studies were rather extreme compared to the intervention used for the 
RyeWeight study [192, 193]. Nonetheless, conclusions regarding the influence of the baseline 
microbiota on weight loss should be drawn with great caution. The study was not specifically 
designed for investigating the effect of gut microbiota on weight loss, but considering recent 
advances in the field, collection of a fecal sample before initiation of the run-in period would 
have strengthened the design of the study.  
 
5.3 Effect of rye consumption on metabolic risk markers 
Both the RyeWeight and the RyeClaim studies revealed some effects of the intervention on 
metabolic risk markers. As the RyeWeight study was designed as a weight loss study and 
succeeded in inducing a weight loss that differed between the groups, the results on 
metabolic risk markers should be interpreted with caution since it cannot be ruled out that 
they are to some extent affected by the weight loss. 
  
5.3.1 Inflammation 
One of the most interesting findings from the RyeWeight study, beyond the weight loss, was 
a rather large decrease in CRP (Figure 5.7). CRP concentration remained stable in the wheat 
group, but decreased in the rye group and was almost 30% lower than in the wheat group 
after 12 weeks of intervention. The statistical analysis was adjusted for change in body weight 
and the change in CRP did not appear to be correlated with change in body weight. Thus, this 
reduction in CRP cannot be explained solely by weight loss, especially considering the fact 
that this is not the first time rye intake has been associated with reduction in inflammatory 





Figure 5.7: Summary of the difference between the rye group and the wheat group after 6 and 12 
weeks of intervention in the RyeWeight study. As the outcome measures were not normally distributed, 
the data were transformed to a natural logarithmic scale before analysis and the estimates were then 
back-transformed to the original scale for interpretation. The estimates are therefore to be interpreted 
as the ratio between the groups and 95% confidence intervals. The rye group was set as the reference 
and a bar reaching above 1 means that the concentration in the wheat group was higher than that in 
the rye group. #Observations above 10 mg/l has been omitted* p < 0.05, ** p < 0.01. 
 
The RyeClaim study also showed a reduction in CRP (Figure 5.8). As opposed to the RyeWeight 
study, where the difference was driven solely by a decrease in the rye group, the change in 
CRP in the RyeClaim study was mediated by a combination of an increase in the wheat group 
and a decrease in the rye group. This may be a result of the products being unfamiliar to the 
participants, so that any negative effect of wheat products would appear in this population, 
but not in a population more accustomed to consuming such wheat products, like that in the 
RyeWeight study. It should be noted that the RyeClaim study was conducted in a population 
with an ongoing infection (Helicobacter pylori) which might affect CRP. However, there was 
no indication that the infection was affected by the intervention. Furthermore, the 
differences in CRP had attenuated at week 24, once the participants had returned to their 
habitual diet, which strengthens the notion that the differences in CRP were caused by the 
intervention. 
Nonetheless, the reduction in CRP was substantial in both studies and a good indicator of a 
positive effect of rye consumption on low-grade inflammation. This is supported by findings 
from a cross-over intervention in 17 men with low-grade untreated prostate cancer [194]. In 
this study, an intervention with high amounts of rye products for 6 weeks tended to decrease 
levels of CRP and other inflammatory markers that have been associated with metabolic 
disease risk, compared with refined wheat products [194, 195]. The microbiota analysis from 
the RyeWeight study revealed a reduction in the abundance of [Ruminococcus] torques group 
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in response to the rye diet (Paper II). [Ruminococcus] torques group is known to degrade 
mucus in the human GI tract and has been associated with poor gut barrier integrity and it 
may be that the reductions in CRP brought on by the rye-based intervention were mediated 
through an improved gut barrier function. 
 
 
Figure 5.8: C-reactive protein (CRP) concentration in the RyeClaim study. The participants consumed 
refined wheat products or high fiber rye products with added rye bran according to randomization 
during weeks 0-12 whereafter they returned to their habitual diet. Data are means and standard 
errors of mean. *p<0.05. 
 
5.3.2 Cholesterol 
After 12 weeks of intervention in the RyeClaim study, LDL cholesterol was 0.2 mmol/l lower 
in the rye group than in the wheat group (Figure 5.9). This was driven by a reduction in LDL 
concentration in the rye group that was apparent already at week 6. However, at week 6 the 
LDL concentration in the wheat group had also decreased, meaning that there were no 
significant differences between the groups at that time. The reduction in LDL cholesterol in 
the wheat group had diminished at week 12, returning to baseline levels. Interestingly, a 
seemingly opposite pattern was found in the RyeWeight study, where a difference in LDL 
concentration between the groups at week 6 was driven by an increase in the wheat group, 
which had diminished by week 12 (Figure 5.10). These fluctuations in LDL cholesterol 
concentrations over the course of the intervention are difficult to explain. In a recent 
intervention comparing whole grain rye and whole grain wheat in an 8-week cross-over study, 
a significantly lower LDL concentration was found in the rye group after 4 weeks of 
intervention, but had diminished at week 8 [59]. This was not explained by changes in 
compliance as measured by plasma AR concentrations. Cereal fiber has been shown to be 
associated with lower cholesterol concentration and reduced disease risk, while refined grain 
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consumption has been associated with increased risk of cardiovascular disease and it could 
be theorized that consumption of high fiber rye-based cereals might reduce cholesterol 
concentration in a similar manner as oat-based cereals [65, 196, 197]. However, the 
fluctuations repeatedly seen in cholesterol concentration following rye consumption warrant 
further research on the topic and highlight the need for studies with a relatively long duration 
and frequent sampling to capture this phenomenon.  
 
Figure 5.9: Total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol 
concentrations in the RyeClaim study. The participants consumed refined wheat products or high 
fiber rye products with added rye bran according to randomization during weeks 0-12 whereafter 




Figure 5.10: Summary of the mean differences and 95% confidence intervals between the rye group 
and the wheat group after 6 and 12 weeks of intervention in the RyeWeight study. The rye group was 
set as the reference when calculating the difference between the groups, so if the bar reaches above 




6 GENERAL DISCUSSION 
 
The overall aim of this thesis was to investigate the effects of rye-based cereal products on 
body weight and metabolic risk markers, and the potential roles of appetite regulation and 
gut microbiota. Rye-based products were shown to induce greater weight loss than wheat-
based products, as well as inducing some beneficial effects on metabolic risk markers. In the 
following, I will discuss some general methodological issues related to the studies included in 
this thesis, as well as summarizing the main findings of the thesis and how they contribute to 
further understanding of the health effects of rye.  
 
6.1 Methodological considerations 
 
6.1.1 Choice of intervention products and compliance 
All three studies included in this thesis used refined wheat-based products with a relatively 
low fiber content as the control treatment, whereas the rye-based products contained whole 
grain and in one study, added rye bran, which made them higher in dietary fiber than the 
control products. This means that it can be difficult to distinguish the effects of rye per se 
from the effects of cereal fiber, associated bioactive compounds and whole grain.  
The rationale behind selection of products, especially in the RyeWeight study, was that the 
typical rye products on the market are relatively high in whole grain and cereal fiber, whereas 
the typical wheat products are based on refined wheat. From a public health perspective, it 
is therefore highly relevant to investigate the effect of replacing existing wheat products with 
existing rye products rich in whole grains and dietary fiber, in line with the dietary guidelines. 
This being said, it is still interesting to compare different sources of whole grain to disentangle 
the potential effects of whole grain vs. refined grain and different cereal sources. Two studies 
including both a refined wheat arm, a whole grain wheat arm and a whole grain rye arm have 
been conducted previously [89, 108]. This design gives the opportunity to investigate the 
effect of whole grain vs. refined grain, as well as the potential differences between cereal 
sources, but both studies had a relatively low number of participants in each arm and thus 
had limited statistical power to detect clinically meaningful differences. Though it could have 
been interesting to include another treatment arm in the RyeWeight study, for instance with 
whole grain wheat-based products or refined rye products, it would have had some 
implications: either the power would have been reduced or there would have been a need to 
increase the enrollment, which can be a challenge in practice. Furthermore, one of the 
previously mentioned studies indicated that whole grain rye was superior to whole grain 
wheat in terms of inducing weight loss [108], which would justify the choice of comparing 
whole grain rye with refined wheat at a larger scale.  
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Another option could be to exclude the refined wheat arm and only include two different 
whole grain groups. A study by Eriksen et al. compared whole grain rye and whole grain 
wheat, matched for cereal fiber content by adding wheat bran to the whole grain wheat 
products [59]. This gave the opportunity to investigate the effect of the whole grain source, 
without the influence of differing amounts of cereal fiber, and indicated that rye was superior 
to wheat in terms of lowering LDL cholesterol, independent of fiber content [59]. However, it 
is important to remember that different cereals have different amounts of fiber in their native 
form [81], so in practice a 100% whole grain rye product will have a higher fiber content than 
a 100% whole grain wheat product. Ultimately, choice of control treatment is a challenge in 
dietary intervention studies and should be made carefully, to fit the research question [198, 
199]. 
In the context of the RyeClaim study, neither the rye products nor the wheat products were 
similar to any products available in the market or habitually consumed in the population 
where the study was conducted. However, the aim of this study was to proof a concept of 
using a combination of whole grain rye and fermented rye bran to manage Helicobacter pylori 
infection, rather than testing a diet with immediate potential for utilization. As rye is generally 
not consumed in countries with a high Helicobacter pylori incidence, it was necessary to 
conduct the study in a population that was not used to consuming rye-based products and 
unfamiliarity with the products was thus difficult to avoid. In retrospect, the poor compliance 
indicates that more care could have been taken to ensure that the intervention products were 
palatable for the participants. This highlights an important aspect of designing dietary 
interventions, that should not be neglected. Good compliance is an important factor for 
producing robust evidence [75, 200], so one should take measures to facilitate compliance 
and ensure that the intervention is well accepted by the participants. Furthermore, this also 
highlights the importance of measuring compliance in intervention studies [201]. Compliance 
is often measured by having the participants report their intake of intervention products or 
by having participants return unused intervention products [202, 203]. However, these 
measures are prone to bias and should ideally be supplemented with more objective 
measures, such as dietary biomarkers – which were used in the studies included in this thesis. 
Without dietary biomarkers, lack of compliance would not have been detected in the 
RyeClaim study.  
While rye breads are often made using sourdough, the breads used in the RyeWeight and 
RyeClaim studies were made without sourdough, to prevent any potentially confounding 
effect of comparing yeast-fermented wheat breads with sourdough-fermented rye breads. 
The Sourdough study showed no effect of sourdough fermentation on postprandial appetite. 
However, sourdough could have other effects, for instance related to bioavailability and 
structural properties of the bread, that may affect health outcomes [204]. Furthermore, 
sourdough can be based on a range of different cereal ingredients and yeast cultures and 




6.1.2 Appetite assessment 
It was hypothesized that weight loss induced by rye consumption could be mediated through 
increased satiety. This was not confirmed by the studies included in this thesis, but 
methodological issues may have affected the results.  
There are currently few studies that have conducted home-based appetite assessments and 
therefore little is known about the validity of such measurements, compared with the 
traditional clinic-based appetite assessments. One study comparing appetite response to 
whole grain-based products in a clinical setting with that in an at-home setting found appetite 
response in the two settings to be comparable [205]. However, more studies are needed to 
validate the home-based approach. Home-based appetite assessments can probably provide 
valuable insight into appetite regulation under free-living conditions and help us understand 
how the body of evidence from clinic-based studies translates into real-life settings. 
Furthermore, home-based appetite assessment offers practical advantages in terms of 
reducing the need for clinical facilities to conduct appetite assessments and participants may 
also find it appealing to conduct study activities outside the clinical setting. This feeds into an 
ongoing trend within the field of medical research where decentralized and virtual trials are 
gaining momentum [206–208]. 
 
6.2 Rye and health – evidentiary status 
 
6.2.1 Body weight management 
Studies in this thesis have provided evidence that rye has a beneficial effect when it comes to 
reducing body weight and body fat, but the mechanism(s) behind this effect remain unclear 
and warrant further research.  
Considering the large body of studies showing a satiety-enhancing effect of rye-based 
products (Table 3.2), it is worth considering appetite regulation as a potential mechanism, 
even though no such mechanistic link was found in the RyeWeight study. As previously 
discussed, the methodology used to evaluate satiety in a home setting needs to be optimized 
and validated and the link between inducing satiety and inducing weight loss should be 
investigated further. In addition, the potential role of satiation is worth considering. No study 
to date has investigated the satiating effect of rye-based products, but from a theoretical 
point of view, satiation induced by rye-based products could lead to a lower energy intake 
within a meal, which could contribute to lower overall energy intake and, consequently, 
weight loss [125]. Additional mechanisms, such as fecal energy excretion and energy 
expenditure, could also be worth including in future studies. Studies in ileostomy patients 
have shown increased energy content in the ileal digesta following consumption of rye 
products, compared with wheat products, which indicates that a lower proportion of the 
energy in the food is absorbed in the upper GI tract when rye products are incorporated in 
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the diet [209, 210]. No studies have measured fecal energy excretion following a rye-based 
diet, but consumption of whole grain and dietary fiber has been shown to increase fecal 
energy excretion [211–213]. Thus, it seems plausible that rye products would have the same 
effect, but this remains to be tested. 
As gut microbiota, especially baseline gut microbiota, has recently emerged as a potential 
mediator of weight loss induced by a fiber-rich diet, future studies should consider this [25]. 
Energy extracted from fermentable dietary fiber in the colon, in the form of SCFAs, has 
previously been thought to be a significant source of energy and thus shift the energy balance 
upward [214]. However, the fact that intake of dietary fiber has consistently been associated 
with lower body weight and that concentrations of certain fiber-degrading bacteria have 
recently been correlated with increased weight loss in response to a fiber-rich diet speaks 
against that theory [24, 112, 113]. Rather, it may be that SCFAs, especially propionate, are 
involved in appetite regulation, through their potential effect on satiety-regulating hormones, 
which could explain why a high abundance of SCFA-producing bacteria is associated with 
increased weight loss following a diet high in dietary fiber [121, 135, 215, 216]. This could 
mean that a person with a higher capacity for colonic fermentation and SCFA production 
would respond better to a weight loss diet high in fermentable fiber than a person with lower 
capacity for fermentation. Butyrate was the only SCFA for which the concentration differed 
consistently between the groups in the RyeWeight study. Butyrate has been suggested to be 
involved in the upregulation of the energy expenditure and it could be that the increased 
weight loss in the rye group was partially mediated by this, especially considering the fact that 
neither reported energy intake or subjective appetite differed between the groups [217]. In 
future studies, it could be interesting to include a measure of energy expenditure, though it 
is relatively resource-demanding to perform such measurements in a large group of 
participants [218]. 
The lack of a “true” baseline fecal sample in the RyeWeight study hampered investigation of 
the potential link between baseline gut microbiota and response to the intervention, since 
the 2-week run-in period on refined wheat may have altered the baseline gut microbiota. On 
the one hand, some studies have shown that gut microbiota composition changes rapidly in 
response to dietary change [192, 193]. However, previous cereal-based interventions similar 
to the RyeWeight study have shown limited effects of the intervention on gut microbiota 
composition [57–59, 219]. A solution might be to conduct a model intervention of the run-in 
period, using the same dietary intervention as was used in the RyeWeight study, to increase 
our understanding of how the run-in period may have affected the microbiota composition 
and how the data from the RyeWeight study should be interpreted. 
The RyeWeight study is the first study designed to investigate the effect of rye consumption 
on weight loss and though the results are convincing, the findings should be confirmed in 
other studies before firm conclusions are drawn. While the RyeWeight study was of a 
relatively long duration compared with other whole grain interventions (Table 3.1), it is 
important to consider the more long-term effects of a weight loss intervention. Weight gain 
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following weight loss is far from unusual and long-term weight management is the most 
important aspect to consider for disease prevention [220–222]. Future studies could have 
extended intervention periods, but follow-up periods beyond the intervention period could 
also provide valuable information on the long-term effects of weight loss induced by replacing 
refined wheat-based cereals with whole grain rye-based cereals. 
 
6.2.2 Metabolic risk factors 
A consistent effect of rye consumption on inflammation was found in this thesis and a 
potential association with gut microbiota was revealed. This is consistent with findings of 
another rye-based intervention, showing that a high intake of rye-based products reduced 
levels of several inflammatory markers [194]. It is important to emphasize that none of these 
studies was designed for investigating the effect of rye on inflammation and each has some 
potentially confounding factors, such as weight loss and ongoing disease. Despite this, the 
results are consistent and a potential mechanistic link to gut microbiota has been suggested, 
which would justify designing and conducting a study specifically to investigate the effects of 
rye-based products on inflammation. In such a study, it would be relevant to include 
assessment of other inflammatory markers that may have implications for metabolic and 
cardiovascular disease risk, such as interleukin-6 and tumor necrosis factor-α [223]. 
Furthermore, it could be relevant to include markers of gut barrier integrity, such as zonulin 
[224], in order to investigate the potential association between inflammation and the gut 
[225]. There is no consensus when it comes to cut-offs for CRP in relation to risk of 
cardiovascular disease, but it has been suggested that values of 1–3 mg/l should be 
interpreted as intermediate risk and values > 3 mg/l as high risk [226, 227]. Participants in 
both the RyeWeight and the RyeClaim studies had a baseline CRP of approximately 1.5 mg/l, 
placing them in the intermediate risk group. In both studies, the CRP concentrations in the 
rye group at week 12 were close to the lower limit of 1 mg/l, indicating a reduction in disease 
risk, although it should be noted that they were in the lower range of the intermediate risk 
group already at baseline. 
The studies included in this thesis revealed a potential effect of rye consumption on LDL 
cholesterol. Although not as clear-cut as other results, this raises interest, as it is not the first 
time rye-based products have been associated with favorable effects on blood lipids [59, 78, 
228]. Though the participants in the RyeClaim study had an average LDL concentration within 
normal range at baseline, the magnitude of the reduction was in line with what has been seen 
in studies investigating the cholesterol-lowering effect of beta-glucans, which has been 
deemed sufficient to substantiate an authorized health claim from the European Commission 
[164, 167]. However, at this stage, the results are not sufficiently consistent to draw any 





The work in this thesis showed that: 
 
• Rye-based products with a high fiber content induce a larger weight loss than refined 
wheat products, which indicates that replacing refined wheat products with high fiber 
rye products is beneficial for weight loss. 
 
• The effects of rye-based products on appetite were not convincing and the appetite 
response did not differ between high fiber rye-based products and refined wheat-
based products in an at-home setting. No mechanistic link between increased satiety 
and weight loss could be established. However, methodological issues warrant further 
research before any conclusions can be drawn. 
 
• No consistent link between weight loss and gut microbiota was found, but use of more 
sophisticated analysis methods and a better understanding of how the run-in period 
may have affected the baseline gut microbiota could potentially lead to additional 
findings. 
 
• Rye was shown to induce a consistent attenuating effect on inflammation, compared 
with refined wheat products, though these results should be interpreted with care 
due to potential confounding. Rye may affect LDL cholesterol, but the effects were 
inconsistent and warrant further research. Changes in gut microbiota induced by rye 






8 FUTURE PERSPECTIVES 
 
• Confirmation of the effect of rye on body weight in other studies is warranted, 
especially if one were to pursue a health claim on the effect or in other ways use it in 
marketing of rye products.  
 
• Long-term weight maintenance is an important aspect of weight management and 
follow-up studies, for instance 1–2 years after the end of an intervention, would aid 
the understanding of the long-term implications of a weight loss induced by replacing 
wheat products with rye products. Studies of longer duration and studies including a 
weight maintenance phase, in addition to a weight loss phase, could also provide 
valuable information on the potential use of rye for weight maintenance.  
 
• Further investigation of the potential role of gut microbiota, potentially through 
sequencing of gut microbiota on a deeper level, more advanced statistical analysis 
methods and carefully planned sample collection, could likely increase our 
understanding of some of the underlying mechanisms of weight loss induced by a 
dietary intervention. 
 
• Methods suitable for measuring subjective appetite under free-living conditions 
should be developed. This could for instance be done by comparing the home- and 
clinic-based appetite responses to identical foods in order to improve our 
understanding of how we can interpret appetite responses measured in different 
settings and identify aspects of the methodology that can be optimized for these 
different settings. Furthermore, there is a need to develop and validate new tools for 
appetite assessment, such as a smartphone application. 
 
• The effects on inflammation warrant further research. A first step could be to utilize 
biobank material from the RyeWeight study to measure additional inflammatory 
markers, as well as markers of gut permeability. At some point, a study specifically 
designed to investigate the effect of rye consumption on inflammation, without the 
confounding factor of weight loss, will be needed to establish causality. 
 
• A study designed to investigate the effect of rye consumption on inflammation could 
potentially also be utilized to investigate the effect on blood lipids. Ideally, relatively 
frequent sampling (e.g., every second week) should be implemented to capture the 
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